20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T38237 | 2′-O-Methylcytidine | Nucleoside Antimetabolite/Analog , HCV Protease | |
2'-O-Methylcytidine is a nucleoside derivative and an inhibitor of hepatitis C virus (HCV) non-structural protein 5B (NS5B; IC50= 3.8 μM).1It inhibits HCV replication in a replicon assay (IC50= 21.2 μM). 1.Migliaccio, G.... | |||
TNU0653 | N4-benzoyl-2’-O-methylcytidine | ||
2’-O-Methyl nucleoside | |||
TNU0124 | 2’-O-Methyl-5-methylcytidine | ||
2’-O-Methyl nucleoside | |||
TNU0018 | 5-Iodo-2’-O-methylcytidine | ||
Halo-nucleoside; 2’-O-Methyl nucleoside | |||
TNU0129 | 5-Formyl-2’-O-methylcytidine | ||
Nucleoside Derivatives - 2’-Modified nucleosides, 5-Modifiedpyrimidine nucleosides, Naturally modified Ribo-nucleosides | |||
TNU0478 | 3’-O-(2-Methoxyethyl)-5-methylcytidine | ||
Nucleoside Derivatives - 3’-Modified nucleosides | |||
T75224 | N4-Benzoyl-3'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine | ||
N4-Benzoyl-3'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine | |||
TNU0809 | 3,5’-Bis(O-t-butyldimethylsilyl)-2’-O-methyl-5-methylcytidine | ||
Nucleoside Derivatives - 5-Modified pyrimidine nucleosides,2’-Modified nucleosides; Protected nucleosides with NH2/OH group | |||
TNU1365 | 2'-Deoxy-5'-O-DMT-5-methylcytidine | ||
Nucleoside Derivatives - Protected nucleosides w/NH2/OH open | |||
TNU1114 | N4-Benzoyl-2’-O-(2-methoxyethyl)-5-methylcytidine | ||
Nucleoside Derivatives - 2’-Modified nucleoside | |||
TNU1602 | N4-Benzoyl-3'-O-(4,4’-dimethoxytrityl)-2'-O-(2-methoxyethyl)-5-methylcytidine | ||
N4-Benzoyl-3'-O-(4,4’-dimethoxytrityl)-2'-O-(2-methoxyethyl)-5-methylcytidine is a useful organic compound for research related to life sciences and the catalog number is TNU1602. | |||
TNU1115 | N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O-(2-methoxyethyl)-5-methylcytidine | ||
Nucleoside Derivatives - 2’-Modified nucleoside, Protected nucleosides with NH2/OH open; Ready for phosphorylation | |||
TNU1361 | N4-Benzoyl-3’-O-(2-methoxyethyl)-5-methylcytidine | ||
Nucleoside Derivatives - 3’-Modified nucleosides | |||
TNU1362 | N4-Benzoyl-5’-O-DMT-3’-O-(2-methoxyethyl)-5-methylcytidine | ||
Nucleoside Derivatives - 3’-Modified nucleosides; Protected nucleosides w/NH2/OH open | |||
TNU1225 | 2'-Deoxy-5'-O-DMT-N4-Fmoc-5-methylcytidine | ||
Nucleoside Derivatives –2’-Modified nucleosides; Thio-nucleosides | |||
TNU0975 | N4-Benzoyl-2’-deoxy-5’-O-DMTr-2’-fluoro- 5-methylcytidine | ||
N4-Benzoyl-2’-deoxy-5’-O-DMTr-2’-fluoro- 5-methylcytidine is a useful organic compound for research related to life sciences and the catalog number is TNU0975. | |||
TNU0853 | N4-Benzoyl-2’,3’-di-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-N4-methylcytidine | ||
Nucleosides Derivatives - Other modified nucleosides | |||
TNU1603 | N4-Benzoyl-3'-O-(4,4’-dimethoxy trityl)-2'-O-(2-methoxyethyl)-5-methylcytidine-5’-CED phosphoramidite | ||
N4-Benzoyl-3'-O-(4,4’-dimethoxy trityl)-2'-O-(2-methoxyethyl)-5-methylcytidine-5’-CED phosphoramidite is a nucleoside phosphoramidite. | |||
TNU0336 | 2'-O-MOE-5-Me-rC | ||
Nucleoside Derivatives - 2’-Modified nucleoside | |||
TNU1116 | 2'-O-MOE-5-Me-C(Bz) | ||
Nucleoside Phosphoramidites; Ready for phosphorylation |